Manganese X
Subsidiary and JV Partner PureBiotic Air Inc.
Provide
Virginia State University Testing
Update
on Biofilm
Deconstruction of Pathogens Including COVID -19
Montréal, Québec, Canada,
May 18,
2021
-- InvestorsHub NewsWire -- Manganese
X Energy Corp. (TSXV: MN) (FSE: 9SC2) (OTCQB:
MNXXF)
("Manganese X",
"MN" or
the "Company")
is pleased to
announce that its wholly owned subsidiary, Disruptive Battery Corp.
("DBC"), in conjunction with its US JV
Partner, PureBiotic AIR, Inc. ("PureBiotic"), has received
additional
positive
preliminary results from its ongoing research study with Virginia
State University (VSU). Early results
indicate that PureBiotic
AIR
Mist
Solutions
can
potentially
be effective
in causing the
deconstruction of biofilm, calculated by the Center for Disease
Control (CDC) to be responsible for
80% of all
infections, thereby reducing the risk
of infection
from pathogenic bacteria and
viruses, including SARS-CoV-2 virus, cause of the COVID-19
pandemic.
Manganese X Energy Corp. CEO
Martin Kepman said, "There were some delays caused by the COVID-19 restrictions
in
accessing VSU testing
facilities, as well as staff
availability. We have
now
been notified that
testing will resume on a regular basis with their staff as long as
there are no additional COVID-19 interruptions".
The initial VSU testing also
included the successful production of
the biofilm growth required to advance its
research and testing of DBC's PureBiotic AIR HVAC Delivery System for the
mitigation of infection risks,
including COVID-19 and other
contaminants. Applications of the PureBiotic
AIR Mist Solutions are currently being tested on the biofilm grown from specific pathogens selected from the
common
human
environment.
The company's
ultimate goal is to create a product for FDA
certification.
With test results now indicating the possibility
that the
PureBiotic AIR Mist Solutions can be effective
in
causing the deconstruction of the biofilm, the VSU research team will continue
its
study to document
the reduction in infection risk. This component of the research
will cover a wide range of infection types, addressing some of the current
concerns due to the COVID pandemic and
its variants, as well as that of the extensive range of Hospital Acquired Infections
(HAI's).
Background
Information on PureBiotic AIR Mist Solutions
This research studies the
possibility of utilizing an easy and safe
removal of biofilm at the microscopic level by testing many other types of infections which may currently
be
eclipsed
by
COVID. These infections
cause millions of hospitalizations
and tens of
thousands of deaths as well as
costing hundreds of billions
of dollars
annually around the
world. Utilizing the
PureBiotic
AIR
Mist
Solutions both on surfaces and
in the
air,
could
potentially help reduce the
viability of
COVID-19
transmission
and
of
other infections by
deconstructing the microscopic biofilm that is present on all
surfaces.
.
A number of previous studies from
universities and
hospitals have documented the significant ability of
PureBiotic AIR Mist Solutions
to control a very
wide range of pathogens, as well as the ability to safely deconstruct
Biofilm. Biofilm, which is found on almost every possible
surface, as well as on
and in
all
life
forms, is the defensive environment grown as protective
housing by microorganisms.
One of the other significant advantages PureBiotic AIR
Mist
Solutions
have
over chemical
solutions in cleaners and disinfectants,
is that
it
is
basically
organically
suspended
in purified
water. The mist has been proven time and again
to be
totally
safe
and beneficial
to all life
forms (and has been certified by a number of Organic
Organizations as approved for use on Certified-Organic animals). Applications of PureBiotic AIR Mist
Solutions
should
provide
ongoing
continuous
protection
long after
the initial
application. The PureBiotic AIR Mist Solution
also
is
extremely
environmentally
friendly
and
its
formulation has met all the major
certifications for
being Green Seal Certified as well as NFS and other certifications
Another important additional benefit
of
PureBiotic
AIR
Mist
Solutions is that it is not like
other disinfectants
which
are
basically
poisons
with
toxic
ingredients that normally stop working as
soon as they are dry. This leaves untold billions of dead
microscopic life forms impossible to remove from the
cleaned surfaces and these become a
continuous
"Free Lunch"
for the first
opportunistic organism (like the extremely ubiquitous staphylococcus)
that lands on
that "cleaned"
surface. But, even far more
important, is that chemical disinfectants
kill
everything, including the protective good bacteria that are needed, so "all the competition is
gone" resulting in
Staph
Colonies
that
can happily
have huge
growth spikes. However, PureBiotic Air Mist Solutions keep working
after drying
for days after each
application which potentially
protects and removes contaminants
24/7.
The company is not making any
express or implied claim that it has developed a COVID-19 air
management solution at this time.
About Manganese X Energy Corp.
Manganese X's mission is to advance its Battery Hill project into
production, with the intent of supplying value-added materials to
the lithium-ion battery and other alternative energy industries,
The Company is also striving to achieve new carbon-friendly more
efficient methodologies, while processing manganese at a lower
competitive cost. The company is the only manganese company in
North America moving toward commercialization of
a manganese deposit.
Subsidiary Disruptive Battery Corp.'s mission is to develop an HVAC
(heating, ventilation and air conditioning) air purification
delivery system for cleaner and healthier air, aiming to mitigate
COVID-19 and other contaminants
on surfaces and in the air.
For more
information visit the website at
www.manganesexenergycorp.com
On behalf of
the Board of Directors of
MANGANESE X ENERGY CORP.
Martin
Kepman
CEO and
Director
Email: martin@kepman.com
Tel: 1-514-802-1814
Cautionary
Note Regarding Forward-Looking Statements:
Neither
TSX Venture Exchange nor its Regulation Services Provider (as that
term is defined in the policies of the TSX Venture Exchange)
accepts responsibility for the adequacy or accuracy of this
release.
This news
release contains "forward-looking information" including statements
with respect to the future exploration performance of the Company.
This forward-looking information involves known and unknown risks,
uncertainties and other factors which may cause the actual results,
performance or achievements of the Company to be materially
different from any future results, performance or achievements of
the Company, expressed or implied by such forward-looking
statements. These risks, as well as others, are disclosed within
the Company's filing on SEDAR, which investors are encouraged to
review prior to any transaction involving the securities of the
Company. Forward-looking information contained herein is provided
as of the date of this news release and the Company disclaims any
obligation, other than as required by law, to update any
forward-looking information for any reason. There can be no
assurance that forward-looking information will prove to be
accurate and the reader is cautioned not to place undue reliance on
such forward-looking information. We seek
safe harbor.
Manganese X Energy (TSXV:MN)
과거 데이터 주식 차트
부터 10월(10) 2024 으로 11월(11) 2024
Manganese X Energy (TSXV:MN)
과거 데이터 주식 차트
부터 11월(11) 2023 으로 11월(11) 2024
